Plotting clinical entry, James Wilson’s gene therapy startup brings in billionaire for $110M Series B

The gene therapy biotech that James Wilson helped found to take some rare disease programs out of Penn all the way to an approval has scored $110 million in its latest financing.

Leave a Reply

Your email address will not be published. Required fields are marked *